Jure Sokolić holds the position of Head of Division for Pharmaceutical MES (Manufacturing Execution System), Operational Excellence (OPEX), and Serialization Programs at Metronik. In this role, he is responsible for overseeing product management of MePIS MES and leading implementation teams to ensure the successful delivery of solutions.

He possesses extensive expertise across a broad spectrum of domains, including data science, the design and development of digital solutions, project management, and Good Manufacturing Practice (GMP) life cycle management. His diverse background uniquely equips him to lead innovative product development initiatives and deliver complex solutions within the pharmaceutical manufacturing sector.

Jure Sokolić earned a diploma in Electrical Engineering from the University of Ljubljana and subsequently obtained a PhD in Electrical Engineering from University College London.

Metronik is a trusted and innovative provider of digital transformation and manufacturing management solutions and products, specialized for the life-science industry. Its MES and OT/IT integration products and solutions based on modular MePIS platform are being used by several respectful pharmaceutical and biotech companies. By combining extensive knowledge of manufacturing processes and regulatory requirements in life-science industries with state-of-the-art automation and digitalization technologies, Metronik helps its business partners and customers in pharma and biotech industry to increase their competitive advantage through improved management and control of their processes, identification of cost-saving opportunities and development of optimization initiatives. Company was established in 1990 and now employs more than 180 engineers and programmers in three countries. Beside MePIS platform development a company also provides system integration and life-cycle capabilities in the fields of automation, process control and digital transformation. A company has its customers and business partners in Belgium, Germany, Ireland, France, Switzerland and many other EU countries, as well as in Eastern Europe and Asia.